68Ga-PSMA-HBED-CC PET/CT衍生的总分子肿瘤体积的可重复性
结果显示,半自动MTVtotal的重复性系数为35%(95% CI 25%-50%),且读者间稳健;而单个病灶体积重复性较差(RC 77%)。结论认为,半自动MTVtotal变化±35%代表肿瘤体积的真实变化。
要点
- 半自动MTVtotal的重复性系数为35%,变化±35%提示真实肿瘤体积改变。
- 单个手动勾画病灶的MTV重复性较低(RC 77%)。
- 交替读者间MTVtotal的RC为37%,表明指标对读者稳健。
核心结论
- 68Ga-PSMA-HBED-CC PET衍生的半自动MTVtotal具有可重复性且不依赖读者,变化±35%代表肿瘤体积的真实变化。
主要发现
- 单个病灶MTV的重复性系数为77%(95% CI 63%-96%)。
- 按患者聚合最多10个手动选择病灶后,重复性系数改善至33%(95% CI 25%-46%)。
- 半自动MTVtotal的重复性系数为35%(95% CI 25%-50%),Bland-Altman偏倚为-6.70(95% CI -14.32-0.93)。
- 两次扫描交替读者时MTVtotal的重复性系数为37%(95% CI 28%-49%)。
关键数值与推荐
- 半自动MTVtotal变化±35%可认为代表肿瘤体积的真实变化。
- 单个病灶MTV重复性系数77%(95% CI 63%-96%),聚合病灶后为33%(95% CI 25%-46%)。
临床怎么用
- 可采用半自动MTVtotal评估前列腺癌患者总肿瘤负荷及治疗反应,变化±35%视为真实改变。
- 单个病灶手动体积测量重复性较低,不宜单独用于疗效监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Molecular tumor volume (MTV) is a parameter of interest in prostate cancer for assessing total disease burden on prostate-specific membrane antigen (PSMA) PET. Although software segmentation tools can delineate whole-body MTV, a necessary step toward meaningful monitoring of total tumor burden and treatment response through PET is establishing the repeatability of these metrics. The present study assessed the repeatability of total MTV and related metrics for 68Ga-PSMA-HBED-CC in prostate cancer. Methods: Eighteen patients from a prior repeatability study who underwent 2 test-retest PSMA PET/CT scans within a mean interval of 5 d were reanalyzed. Within-subject coefficient of variation and repeatability coefficients (RCs) were analyzed on a per-lesion and per-patient basis. For the per-lesion analysis, individual lesions were segmented for analysis by a single reader. For the per-patient analysis, subgroups of up to 10 lesions (single reader) and the total tumor volume per patient were segmented (independently by 2 readers). Image parameters were MTV, SUVmax, SUVpeak, SUVmean, total lesion PSMA, and the related metric PSMA quotient (which integrates lesion volume and PSMA avidity). Results: In total, 192 segmentations were analyzed for the per-lesion analysis and 1,662 segmentations for the per-patient analysis (combining the 2 readers and 2 scans). The RC of the MTV of single lesions was 77% (95% CI, 63%-96%). The RC improved to 33% after aggregation of up to 10 manually selected lesions into subgroups assessed per patient (95% CI, 25%-46%). The RC of the semiautomatic MTVtotal (the sum of all voxels in the whole-body total tumor segmentation per patient) was 35% (95% CI, 25%-50%), the Bland-Altman bias was -6.70 (95% CI, -14.32-0.93). Alternating readers between scans led to a comparable RC of 37% (95% CI, 28%-49%) for MTVtotal, meaning that the metric is robust between scanning sessions and between readers. Conclusion:68Ga-PSMA-HBED-CC PET-derived semiautomatic MTVtotal is repeatable and reader-independent, with a change of ±35% representing a true change in tumor volume. Volumetry of single manually selected lesions has considerably lower repeatability, and volumetry based on subgroups of these lesions, although showing acceptable repeatability, is less systematic. The semiautomatic analysis of MTVtotal used in this study offers an efficient and robust means of assessing response to therapy.
引用
- Seifert R, Sandach P, Kersting D, et al. Repeatability of 68Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor Volume. J Nucl Med. 2021. PMID: 34446454. doi:10.2967/jnumed.121.262528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。